[go: up one dir, main page]

AR092939A1 - Vacuna contra cooperia - Google Patents

Vacuna contra cooperia

Info

Publication number
AR092939A1
AR092939A1 ARP130103642A ARP130103642A AR092939A1 AR 092939 A1 AR092939 A1 AR 092939A1 AR P130103642 A ARP130103642 A AR P130103642A AR P130103642 A ARP130103642 A AR P130103642A AR 092939 A1 AR092939 A1 AR 092939A1
Authority
AR
Argentina
Prior art keywords
nucleotide sequences
cooperia
proteins
methods
recombinant dna
Prior art date
Application number
ARP130103642A
Other languages
English (en)
Inventor
Claerebout Edwin
Vercruysse Jozef
Geldhof Peter
Borloo Jimmy
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of AR092939A1 publication Critical patent/AR092939A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Secuencias de nucleótidos que codifican antígenos de Cooperia, así como con moléculas de ADN recombinante que contienen a dichas secuencias de nucleótidos y con células huésped que expresan estas secuencias de nucleótidos. Se relaciona además con proteínas de Cooperia, con métodos para la producción de las proteínas, las secuencias de nucleótidos, moléculas de ADN recombinante y huéspedes. Aún más, se relaciona con vacunas que inducen una inmunidad protectora contra una infección por nematodos parásitos tales como especies del género Cooperia y con métodos para preparar dicha vacuna. Vector, uso, método de vacunación.
ARP130103642A 2012-10-09 2013-10-08 Vacuna contra cooperia AR092939A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187773 2012-10-09

Publications (1)

Publication Number Publication Date
AR092939A1 true AR092939A1 (es) 2015-05-06

Family

ID=47018872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103642A AR092939A1 (es) 2012-10-09 2013-10-08 Vacuna contra cooperia

Country Status (7)

Country Link
US (2) US10105424B2 (es)
EP (1) EP2906588B1 (es)
AR (1) AR092939A1 (es)
BR (1) BR112015007678B1 (es)
CA (1) CA2886450C (es)
ES (1) ES2717441T3 (es)
WO (1) WO2014056885A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014056885A1 (en) * 2012-10-09 2014-04-17 Universiteit Gent Cooperia vaccine
KR20240019862A (ko) 2017-09-01 2024-02-14 벤 바이오사이언시스 코포레이션 진단 및 치료 모니터링용 바이오마커로서의 당펩티드의 식별 및 용도
WO2024089248A1 (en) * 2022-10-27 2024-05-02 Universiteit Gent Recombinant activation-associated secreted protein
CN116466074A (zh) * 2023-03-20 2023-07-21 吉林大学 基于特异性抗原fhh的肝片吸虫胶体金检测方法
WO2025186359A1 (en) * 2024-03-06 2025-09-12 Academisch Ziekenhuis Leiden (Publiekrechtelijk Rechtspersoon) Single domain activation-associated secreted protein and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE69101683T2 (de) 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
US5525508A (en) 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine
US6071518A (en) * 1992-05-29 2000-06-06 The Regents Of The University Of California GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
WO1998001550A2 (en) 1996-07-04 1998-01-15 Universiteit Utrecht Vaccine against gastro-intestinal nematodes
CN1997390B (zh) 2004-04-05 2012-10-10 辉瑞产品有限公司 微流化水包油乳状液和疫苗组合物
US20090325204A1 (en) * 2008-06-27 2009-12-31 Reed Steven G Compounds and methods for diagnosis and treatment of chagas disease
JP6110066B2 (ja) 2008-10-08 2017-04-05 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． アナプラズマ・ファゴサイトフィルム（Ａｐｈ）およびアナプラズマ・プラチス（Ａｐｌ）に特異的な抗体を検出するための組成物および方法
GB0922099D0 (en) 2009-12-18 2010-02-03 Moredun Res Inst Parasite Vaccine
WO2014056885A1 (en) * 2012-10-09 2014-04-17 Universiteit Gent Cooperia vaccine

Also Published As

Publication number Publication date
US20150265687A1 (en) 2015-09-24
BR112015007678A2 (pt) 2017-08-08
WO2014056885A1 (en) 2014-04-17
BR112015007678B1 (pt) 2022-12-13
ES2717441T3 (es) 2019-06-21
CA2886450A1 (en) 2014-04-17
CA2886450C (en) 2021-10-26
US10105424B2 (en) 2018-10-23
US10946077B2 (en) 2021-03-16
EP2906588B1 (en) 2018-12-05
EP2906588A1 (en) 2015-08-19
US20180369349A1 (en) 2018-12-27

Similar Documents

Publication Publication Date Title
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
AR134186A2 (es) Un anticuerpo anti-csf-1r, un proceso para producirlo, una composición farmacéutica que lo comprende, una secuencia de adn aislado, un vector de expresión o clonación y una célula hospedadora
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
PE20142406A1 (es) Antigenos asociados a prostata y regimenes de inmunoterapia basados en vacuna
CO2018012513A2 (es) Anticuerpos
MX346245B (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
EA201591287A1 (ru) Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения
BR112014018396A8 (pt) Imunógenos para vacinação contra hiv
BR112015005987A2 (pt) vacina, métodos para induzir uma resposta imune contra um antígeno hbv, para proteção de um sujeito da infeção por hbv, para proteger o sujeito que foi diagnosticado com uma infecção por hbv, para induzir uma resposta imune contra um antígeno do hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um indivíduo da infecção pelo hbv, para proteger um indivíduo que foi diagnosticado com infecção pelo hbv, para proteger um sujeito contra infecção por hbv e para proteger o sujeito que foi diagnosticado com uma infecção por hbv, molécula de ácido nucleico, e, proteína
MX362977B (es) Vectores para la transformacion de mycoplasma hyopneumoniae, cepas transformadas de m. hyopneumoniae, y uso correspondiente.
MX391773B (es) Variantes de lipasa y polinucleótidos que las codifican.
PE20160662A1 (es) Anticuerpos especificos para fcrn
MX378857B (es) Celulas huespedes modificadas y usos de las mismas.
MX387400B (es) Células de mamífero que expresan antígenos de citomegalovirus.
AR092939A1 (es) Vacuna contra cooperia
MX2017000169A (es) Un poliepitope quimerico de virus de dengue compuesto por fragmentos de proteinas no estructurales y su uso en una composicion inmunogenica contra infeccion de virus de dengue.
MX377258B (es) Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria.
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
UY36617A (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
MX2015013304A (es) Vacunas de nucleoproteina de la influenza.
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
WO2012178078A3 (en) Use of yscf, truncated yscf and yscf homologs as adjuvants
BR112017023975A2 (pt) variantes de alfa-amilase e polinucleotídeos codificando as mesmas

Legal Events

Date Code Title Description
FG Grant, registration